ArticleMicrobial pathogenesis2026
The post antibiotic effect of streptogramins on gram-positive bacteria primarily arises from the type a component.
Article in Microbial pathogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The post-antibiotic effect (PAE) is the delay in bacterial regrowth following removal of an antibiotic and has important implications for dosing regimens. Several classes of antibiotics generate PAEs including the streptogramins which are comprised of two components, type A and type B, that bind to adjacent sites on the ribosome and act synergistically to inhibit bacterial growth. In the present work, we investigated the activity of the type A and type B streptogramins virginiamycin (VM1) and virginiamycin (VS1) toward two Gram-positive bacteria, Bacillus subtilis and Staphylococcus aureus. In agreement with previous studies, we show that the combination of VM1 and VS1 resulted in synergistic antibacterial activity defined by the minimum inhibitor concentration (MIC). However, the PAE generated by VM1 was similar to that of the VM1 VS1 combination, whereas VS1 generated only a minimal PAE. These data contrast with the general expectation that the synergy resulting from the combination of streptogramins lowers both the MIC and extends the PAE compared to either component alone, and again reflecting fundamental differences in drug activity at fixed concentrations compared to time-dependent activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.